DB
Dare Bioscience, Inc.
SEC filingBiotechnology · San Diego, CA
Amount raised$12.4Msold at filing
Total offering$12.4M
Investors in the raise12count reported to the SEC
FiledAug 20, 2026first sale Aug 17, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Gregory W. MatzDirector
Jessica D. GrossmanDirector
Robin J. SteeleDirector
MarDee Martucci Haring-LaytonExecutive Officer
William H. RastetterDirector
Sabrina Martucci JohnsonExecutive Officer, Director
Susan L. KelleyDirector
Executive officers, directors and promoters as listed on the Form D.